The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells

Damon A Lowes, Carol Wallace, Michael P Murphy, Nigel R Webster, Helen F Galley

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Tendinitis and tendon rupture during treatment with fluoroquinolone antibiotics is thought to be mediated via oxidative stress. This study investigated whether ciprofloxacin and moxifloxacin cause oxidative stress and mitochondrial damage in cultured normal human Achilles' tendon cells and whether an antioxidant targeted to mitochondria (MitoQ) would protect against such damage better than a non-mitochondria targeted antioxidant. Human tendon cells from normal Achilles' tendons were exposed to 0-0.3 mm antibiotic for 24 h and 7 days in the presence of 1 m MitoQ or an untargeted form, idebenone. Both moxifloxacin and ciprofloxacin resulted in up to a 3-fold increase in the rate of oxidation of dichlorodihydrofluorescein, a marker of general oxidative stress in tenocytes (p0.0001) and loss of mitochondrial membrane permeability (p0.001). In cells treated with MitoQ the oxidative stress was less and mitochondrial membrane potential was maintained. Mitochondrial damage to tenocytes during fluoroquinolone treatment may be involved in tendinitis and tendon rupture.

Original languageEnglish
Pages (from-to)323-328
Number of pages6
JournalFree Radical Research
Volume43
Issue number4
DOIs
Publication statusPublished - Jan 2009

Keywords

  • Mitochondria
  • coenzyme Q10
  • MitoQ
  • idebenone
  • antibiotic
  • tendon
  • vitamin-E
  • in-vitro
  • primary culture
  • rat astrocytes
  • redox status
  • ciprofloxacin
  • toxicity
  • tendinitis
  • cytotoxicity
  • tendinopathy
  • coenzyme Q10
  • MitoQ
  • idebenone
  • antibiotic
  • tendon

Cite this